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Abstract
A transient ischaemic attack (TIA) and minor stroke areBackground: 
medical emergencies and often a warning sign of future strokes if remain
untreated. Few studies have investigated the long-term psychosocial
effects of TIA and minor stroke. Secondary prevention and medical
management are often the primary focus with limited access offered for
further psychosocial support. Psychoeducational interventions can provide
education and advice to people with physical health conditions and, with
suitable tailoring, could be appropriate for people after TIA and minor
stroke. This study aims to develop a group psychoeducational intervention
for people after TIA and minor stroke and to test whether it is acceptable
and feasible.
This mixed-methodology study involves two phases: Phase 1) AMethods: 
qualitative study to determine the content of a suitable intervention; Phase
2) A single-centre feasibility randomised controlled trial to evaluate the
acceptability of this intervention. The overall study has ethical approval.
Stroke survivors have been involved in designing and monitoring the trial.
The aim is to recruit 30-40 participants from a Stroke/TIA Service, within 6
months following their diagnosis. Participants will be randomly allocated to
either the usual care control group or the intervention group
(psychoeducational programme). The programme will consist of six group
sessions based on providing education, psychological and social support.
The primary outcomes will relate to the feasibility aims of the study.
Outcomes will be collected at 3 and 6 months to assess mood, quality of
life, knowledge and satisfaction, and resource use.
There is a need to develop and evaluate effectiveDiscussion: 
interventions that enhance the education provided to people after TIA and
minor stroke and to promote their psychosocial wellbeing. Findings will
indicate the acceptability of the intervention and parameters needed to
conduct a definitive trial.
ClinicalTrials.gov ID  ; registered on 15Registration: NCT02550392
September 2015; status: completed.
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National Health Service; PPI, Patient and Public Involvement; 
R&D, Research & Development; RCT, Randomised Controlled 
Trial; REC, Research Ethics Committee; TIA, Transient Ischaemic 
Attack.
Introduction
Background and rationale
A transient ischaemic attack (TIA), also referred to as a 
‘mini-stroke’, is characteristically a brief and sudden episode 
of focal neurological dysfunction with clinical symptoms that 
typically resolve completely within 24 hours1. A ‘minor stroke’ 
is a term used for stroke patients with mild and non-disabling 
symptoms, but there is considerable variation between studies 
in the criteria used to define a minor stroke2. The National 
Institute of Health Stroke Scale is often used to define a minor 
stroke as a score of ≤3 at the time of initial assessment3.
More than half of all cases of stroke are patients who have 
experienced a TIA or minor stroke4 and considered high risk 
for a subsequent major stroke. Typically, it is assumed that 
TIA and minor stroke patients are expected to make a full 
recovery and to experience only minimal or no functional 
deficits5. However, the Stroke Association has recently 
published a brief report stating that around 70% of people 
with a TIA had reported long-term effects (i.e., memory loss, 
poor mobility, problems with speech and understanding) and 
60% of people reported having been affected emotionally by 
their TIA experience6.
To date, very few studies have addressed the long-term impact 
of TIA and minor stroke, but evidence suggests that patients 
report experiences of certain psychosocial difficulties affect-
ing their quality of life7–9. Currently, secondary prevention 
is the predominant focus of TIA management, and patients 
presenting with no visible or minor impairments are not typi-
cally offered rehabilitation follow-up support or access to 
multidisciplinary stroke services10–12.
Emerging evidence suggests that the psychosocial effects of TIA 
and minor stroke often remain unrecognised and untreated. Psy-
chosocial effects such as anxiety, depression and anger have 
been investigated13–16, but only a few studies have actually 
looked at these emotional effects post-TIA17–20. Regarding the 
risk of depression post-TIA, some studies have found a similar 
association following a stroke21,22. It has been reported that 
TIA patients have similarly high rates of depression (21%) 
and anxiety (29%) as those with stroke from a large regional 
stroke registry study23. Findings from recent systematic 
reviews report TIA patients and minor stroke patients may 
experience residual effects such as depression, fatigue and cog-
nitive difficulties24,25 and anxiety26. Typical emotional difficul-
ties described by TIA patients have been sadness, frustration, 
worries for an uncertain future and loss of confidence27,28.
Psychosocial difficulties can significantly affect the quality of 
life for those following a TIA or minor stroke29 and patients 
are less likely to adhere to secondary prevention precau-
tions. A qualitative study30 found that the experience of a TIA 
can reduce individuals’ quality of life despite the short-term 
nature of their symptoms. Recently, a service evaluation pub-
lished findings suggesting that there was a considerably high 
proportion of TIA and minor stroke patients with clinically 
significant levels of depression and anxiety compared to a 
healthy control group31. Programmes that have included healthy 
lifestyle counselling and exercise for cardiac rehabilitation 
have shown to be beneficial and could potentially be adapted for 
TIA and stroke patients32,33.
Despite some encouraging evidence to promote emotional 
well-being for people after stroke34,35, it continues to remain 
unclear what support could be offered to reduce distress and to 
promote adherence to secondary prevention. To date there have 
been no studies that have designed and tested an intervention 
offering education to address psychosocial difficulties following 
a TIA and minor stroke.
According to the NHS Improvement Stepped Care Model for 
Psychological Care in Stroke36, using a time-limited interven-
tion could potentially allow a large number of individuals to 
access appropriate services which could improve their qual-
ity of life and stroke rehabilitation outcomes. Self-help leaflets, 
support groups, signposting, provision of information and 
other low-level interventions may be considered more appro-
priate for adjusting to a TIA/minor stroke diagnosis37,38. A 
demand for low-level interventions within physical healthcare 
settings has been increasing since the National Institute of 
Clinical Excellence recommendations for Improving Access in 
Psychological Therapies39.
Access to these interventions are currently limited and mainly 
targeted at patients with mental health problems. For an 
intervention to be affective and suitable for TIA and minor 
stroke survivors, content and delivery will require tailoring 
towards their needs.
Psychoeducation is a potential approach which necessitates 
the provision of information and self-help strategies that can 
empower individuals to manage and cope with their difficulties40. 
Psychoeducational interventions have already been effec-
tively delivered in patients with physical illnesses40, and in 
stroke family caregivers41. Such interventions can be brief and 
delivered in a group setting to address cost-effectiveness and 
social support42. This evidence justifies greater focus on the 
psychosocial impact of TIA/minor stroke and development of 
an appropriate intervention.
Research aim and objectives
The aim of this research is to develop a time-limited psych-
oeducational intervention that can be delivered in a group 
format for people with TIA and minor stroke and to evaluate 
the acceptability and feasibility of a randomised controlled trial 
(RCT). A qualitative study with people after TIA/minor stroke 
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and expert clinicians and researchers will be initially conducted 
to help develop the psychoeducational intervention (Phase 1). 
This protocol mainly describes the single-centre feasibility 
RCT (Phase 2) to determine the acceptability of the proposed 
intervention and the parameters to design a definitive trial.
Primary objective. The primary objective is to determine 
whether it is feasible to conduct a RCT to evaluate a group 
psychoeducational intervention for people after TIA and minor 
stroke.
Secondary objectives. The secondary objectives are to test 
the integrity of the study protocol, such as the methods of 
data collection, randomisation procedures and the blinding of 
independent assessors.
•    Can we identify participants willing to be randomised?
•    Consent and drop-out rates
•    Appropriateness of inclusion/exclusion criteria
•    Can we deliver the intervention as planned?
Figure 1. OPTIMISM Study Flowchart.
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•    Can we retain participants in the study?
•    What are the most relevant outcome measures?
Methods and analysis
Study design and setting
The OPTIMISM study has two distinct phases. Phase 1 
(Qualitative Study), outlined in Figure 1, focused on the devel-
opment of the intervention. Phase 2 (Feasibility Trial), described 
here in further detail, focuses on delivering the intervention 
within a single-centre feasibility RCT. The feasibility trial 
protocol methods adhere to the Standard Protocol Items 
Recommendations for Interventional Trials (SPIRIT) guidelines 
for the reporting of study protocols43 (see Reporting guidelines).
The feasibility RCT is a parallel group, two-arm trial with a 
1:1 allocation ratio of a group-based psychoeducational inter-
vention versus a usual care control. We will adhere to the 
recommendations and ethical considerations proposed by the 
Standard Protocol Items for Randomized Trials (SPIRIT)43 
statement guidelines. Participants will be people diagnosed 
with TIA and minor stroke recruited from a Stroke/TIA Service.
Participants
The timeline and proposed flow of participants through the 
feasibility trial (Phase 2) is shown in Figure 1. Participant 
information materials are available as Extended data44.
The inclusion criteria are as follows: 
•    Aged 18 years or over
•     Have a confirmed diagnosis of first or recurrent TIA 
or minor stroke
•    Are independent with activities of daily living after 
diagnosis
•    Are identified within 6 months following diagnosis of 
TIA or minor stroke
•    Able to provide informed consent
Exclusion criteria are as follows: 
•    Are not able to communicate in English
•    Have a diagnosis of dementia prior to the TIA/minor 
stroke that would impact their ability to complete base-
line questionnaires and to participate in group sessions 
(based on self-report by patient/carer and subsequently 
confirmed by checking medical records).
•    Are receiving psychological interventions for mental 
health problems immediately prior to their diagnosis 
of TIA/minor stroke.
•    Have visual (blindness) or auditory (deafness) impair-
ments that would impact on their ability to complete 
baseline questionnaires.
•    Have cognitive or communication difficulties that 
would impact on their ability to complete baseline 
questionnaires and to participate in group sessions.
Intervention development
Phase 1 (Qualitative Study) will involve focus groups or indi-
vidual interviews to explore the views of both people with 
TIA/minor stroke and experts working clinically or conduct-
ing research with people with TIA/minor stroke. Service users 
and experts will be asked to highlight the most important 
difficulties faced after TIA and minor stroke. A topic guide with 
open-ended questions will be used to guide the interview proc-
ess. Data collection and sample size will be determined by 
saturation in themes identified. Results will be analysed using 
thematic analysis to determine the content of an intervention 
for people after TIA and minor stroke.
The intervention will be focused on providing education, 
advice and support within the first six months following 
a TIA and/or minor stroke diagnosis. It will be designed to 
help individuals to identify knowledge and skills to promote 
adjustment, coping and healthier lifestyles.
For each session there will be a presentation containing infor-
mation about a topic and activities to aid group discussion. 
Each session will be facilitated by visual aids such as pres-
entation slides and flipcharts. The topics will be shaped by 
findings from the Phase 1 Qualitative Study. Activities 
during and in-between group sessions will be introduced to 
encourage participants to practice and skills learnt.
Participant workbooks for each session and a facilitator work-
book for the group programme will be developed by the 
research team (see Figure 1). These workbooks will support 
the intervention delivery and will be further developed after the 
end of the feasibility trial. The OPTIMISM group intervention 
programme will be described based on the Template for Inter-
vention Description and Replication (TIDieR) checklist45 
(see Reporting guidelines).
Intervention and comparator
Participants will be randomised after consent and baseline 
assessments to the intervention or usual care control. 
•    Control group: Usual care including all services routinely 
available to them.
•    Intervention group: Usual care plus a group intervention 
based on a psychoeducational framework. This programme 
will be offered in 6 sessions over 2 months. Sessions will be 
delivered face to face in a small group of participants. The 
intervention will be delivered in a suitable place according 
to the availability of space and access for participants. It will 
be facilitated by an assistant psychologist or a trained profes-
sional with matched skills and competences to deliver low-
level group interventions. The group facilitator will receive 
further training from members of the research team 
responsible for the development of the intervention. Each 
session will last approximately 2 hours and will include 
a 15-minute comfort break with refreshments, which will 
allow participants to socialise. Each session will focus on 
providing information about different topics and on devel-
oping problem-solving skills to cope with physical and 
psychosocial difficulties following a TIA or minor stroke.
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Outcomes
Primary outcome measures will mainly pertain to the fea-
sibility aims of the study. Specifically, we are testing the 
feasibility of the trial and the tolerability and acceptability 
of delivering the intervention, study attrition, completing 
the trial and collecting valid and reliable data. This will be 
with the aim to determine the key parameters for conducting 
a larger definitive trial. The feasibility outcome measures 
are: 
•    Feasibility of recruiting TIA and minor stroke patients 
to a group psychoeducational intervention (rates of 
cognitive/mood difficulties, stroke severity, recruitment, 
providing consent, completing intervention, and returning 
outcome questionnaires).
•    Recruitment and exclusion rates (how many patients 
eligible, approached and how many consented, or 
excluded).
•    Completion rates for those who entered into the trial 
(how many completed the intervention/number of 
sessions attended, how many completed and returned 
the follow-up assessments by post, how many follow-up 
assessments required telephone reminders and/or 
face-to-face appointment).
At baseline we will collect sociodemographic details of par-
ticipants including age, gender, ethnicity, employment, living 
arrangements and any relevant medical information (e.g., type 
of stroke, stroke classification etc).
Measures to be completed face-to-face at baseline after informed 
consent: 
•    TIA/stroke severity (NIHSS)46
•    Cognition (Oxford Cognitive Screen (OCS))47
•    Mood (General Health Questionnaire (GHQ-30); Patient Health 
Questionnaire-2 (PHQ-2))48,49
•    Quality of life (EuroQuol-5D-5L (EQ-5D))50
•    Knowledge & feedback questionnaire based on one 
previously published51
•   Resource Use questionnaire
Measures to be completed by post at 3 and 6 months after 
randomisation: 
•    Mood (GHQ-30; PHQ-2)
•    Quality of Life (EQ-5D-5L)
•    Knowledge & feedback questionnaire
•    Resource use questionnaire
Sample size and recruitment strategy
For the qualitative study (Phase 1), a minimum of 10 people 
with TIA or minor stroke and at least six experts will be inter-
viewed. The sample size will be determined by data saturation 
in themes. For the feasibility trial (Phase 2) no formal 
sample size is required. However, a sample size of 30 patients 
or greater is considered adequate to estimate key parameters 
to inform the design of a definite trial52,53. We aim to recruit a 
sample size of 30–40 participants (n=15–20 per group). Recruit-
ment difficulties may affect progress and sample size; however, 
the research team has extensive experience in conducting 
feasibility trials.
The trial opened for recruitment in July 2018 and will be 
open for recruitment until June 2019. Participants will 
be enrolled into the study by a member of staff from the 
Clinical Research Network (CRN) or a member of the research 
team. The CRN/research staff will visit the Stroke wards and 
TIA clinics to provide information about trial to potential 
participants. If they wish to take part, then their permission will 
be sought to be contacted again by the CRN/research team. 
A pre-paid envelope will be provided to anyone who wish to 
return a reply slip with their contact details by post.
The process for obtaining participant informed consent will 
be in accordance with the Research Ethics Committee (REC) 
guidance, and Good Clinical Practice (GCP). Following a full 
explanation of the study, the participant will be required to 
provide informed written consent before they can participate. 
Model consent materials are available as Extended data44.
Randomisation procedure and blinding
Randomisation to each arm on a 1:1 basis and once there 
are 8–12 individuals who have consented and who are able to 
attend the same therapy group (should they be randomised 
to receive it). Randomisation will be conducted using a 
computer-generated randomisation list that will be held on a 
secure server and overseen by an independent member of the 
research team. 
It is not possible for the participants or person delivering the 
intervention to be blind to the group allocation. The research-
ers completing outcome assessments at 3 and 6 months after 
randomisation will be blinded and will not be involved in 
any other aspect of the trial.
Data collection, management and analysis
Data will be collected on a paper-based data collection 
form designed specifically for each phase of the study 
and will subsequently be entered onto a secure electronic 
database. Each participant will be assigned a trial identity code 
number for use on study documents and databases.
When data collection is completed, a data quality check will be 
conducted, and the proportion of missing items will be exam-
ined. Analysis of the outcome data will be conducted on an 
intention to treat basis and will be presented using summary 
statistics. Any differences between the two arms will be cal-
culated at baseline and 6-month follow-up, along with 95% 
confidence intervals. The findings will be used to inform power 
and sample size calculations for a future definitive study and 
to determine appropriateness of these measures. All study 
data will be kept strictly confidential and stored in a secure 
and locked office, and on password-protected databases.
Page 6 of 13
AMRC Open Research 2020, 2:24 Last updated: 08 JUL 2020
Feasibility of completing the intervention
In order to assist in assessing acceptability of the interven-
tion we will provide all the intervention participants with a 
feedback questionnaire during their final session to gather 
information on appropriateness of timing, duration and frequency 
of sessions.
Tolerability will be captured by the proportion of partici-
pants who withdraw or decline the intervention or any sessions 
and the reasons for this. Any adverse events apportioned to be 
as a result of participating in the intervention will be reported.
The integrity of the study protocol will be examined by how 
many participants complete the study, percentage of miss-
ing data, percentage of people who complete questionnaires, 
percentage of people who complete each outcome measure at 
3- and 6-month follow-ups, and calculation of the cost of running 
the study.
PPI
PPI is integrated in all stages of the project, including for 
example the design and conduct of the intervention and 
suggestions in relation to all study materials. During Phase 1, 
PPI will be utilised to establish whether the study is both feasi-
ble and practical and whether the choice of the proposed inter-
vention is something that would be well received by participants. 
PPI will also contribute to the dissemination of research 
findings. By choosing to include PPI in the research 
process we will ensure that the information provided to the 
study participants is user friendly, informative and written in lay 
language. This will help to enhance the recruitment and retention 
of participants to different stages of the project.
Ethics and dissemination
The study is approved by the UK NHS Health Research 
Authority (East Midlands- Nottingham 1 Research Ethics Com-
mittee, ref 15/EM/0453) and the Research & Development 
department of the NHS participating site. This paper reports 
on the study protocol version 4.0, dated 17th May 2018. We 
will conduct our study in line with the Declaration of 
Helsinki54 and according to the principles of GCP55. The sponsor 
for this study is the University of Nottingham, King’s Meadow 
Campus, Nottingham, UK.
Any important protocol amendments will be reported to the 
Health Research Authority, will be registered at ClinicalTrials.
gov and will be communicated to the participating site and study 
sponsor. A Trial Steering Committee with independent members 
will meet to assist in guiding and supervising the project team.
Participants will be informed that they are free to withdraw 
at any time without affecting their future care. Any data col-
lected before their withdrawal may still be used in analysis. For 
participants who cannot attend all group intervention sessions, 
this will be recorded as an outcome. However, they will still be 
asked if they do not wish to receive the postal outcome measures. 
The occurrence of adverse events as a result of participation 
within this study is not expected, since the trial only involves 
a low risk psychological intervention that will be designed 
to improve outcomes and ease distress, and therefore no 
adverse event data shall be collected. If a participant is 
identified as suicidal, then their GP will be informed and the 
usual clinical procedures will be followed by their clinical team.
We plan to disseminate our findings by presenting results at 
national and international stroke and rehabilitation confer-
ences. The RCT results will also be submitted for publication 
to an international, peer-reviewed journal. We will provide trial 
participants with a lay summary of the findings at the end of the 
study if requested. Findings may be further publicised by the 
university, hospital, funder websites and publications.
Trial status
Recruitment on the participating site closed on 30th June 2019 
and the overall trial was completed on 31st January 2020.
Data availability
Underlying data
No underlying data are associated with this study.
Extended data
Figshare: Optimising Psychoeducation for Transient Ischae-
mic Attack and Minor Stroke Management (OPTIMISM): 
Protocol for a Feasibility Randomised Controlled Trial. 
https://doi.org/10.6084/m9.figshare.c.5019200.v144
This project contains the following extended data: 
•    OPTIMISM Research Protocol v4.0, dated 17.05.18
•    OPTIMISM Phase 2 Participant Information Sheet 
v3.0, dated 17.05.18
•    OPTIMISM Phase 2 Participant Consent Form v3.0, 
dated 17.05.18
•    OPTIMISM Phase 2 Poster Information Leaflet v1.0, 
dated 09.11.15
•    OPTIMISM Invitation Reply Slip v1.0, dated 21.09.15
•    OPTIMISM Intervention Outline v2.0, dated 17.05.18
The OPTIMISM participant or facilitator workbooks are 
not currently available publicly as the trial results are not 
yet published. For further details regarding the content of 
the intervention, please contact the corresponding author 
(eirini.kontou@nottingham.ac.uk).
Reporting guidelines
SPIRIT Checklist for Optimising Psychoeducation for Transient 
Ischaemic Attack and Minor Stroke Management (OPTIMISM): 
Protocol for a Feasibility Randomised Controlled Trial. https:// 
doi.org/10.6084/m9.figshare.c.5019200.v144.
TIDieR Checklist for Optimising Psychoeducation for 
Transient Ischaemic Attack and Minor Stroke Management 
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(OPTIMISM): Protocol for a Feasibility Randomised Controlled 
Trial. https://doi.org/10.6084/m9.figshare.c.5019200.v144.
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